Nanomedicines for inflammatory arthritis

Head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes

Lingdong Quan, Yijia Zhang, Bart J. Crielaard, Anand Dusad, Subodh M Lele, Cristianne J F Rijcken, Josbert M. Metselaar, Hana Kostková, Tomáš Etrych, Karel Ulbrich, Fabian Kiessling, Ted R Mikuls, Wim E. Hennink, Gert Storm, Twan Lammers, Dong Wang

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

As an emerging research direction, nanomedicine has been increasingly utilized to treat inflammatory diseases. In this head-to-head comparison study, four established nanomedicine formulations of dexamethasone, including liposomes (L-Dex), core-cross-linked micelles (M-Dex), slow releasing polymeric prodrugs (P-Dex-slow), and fast releasing polymeric prodrugs (P-Dex-fast), were evaluated in an adjuvant-induced arthritis rat model with an equivalent dose treatment design. It was found that after a single i.v. injection, the formulations with the slower drug release kinetics (i.e., M-Dex and P-Dex-slow) maintained longer duration of therapeutic activity than those with relatively faster drug release kinetics, resulting in better joint protection. This finding will be instructional in the future development and optimization of nanomedicines for the clinical management of rheumatoid arthritis. The outcome of this study also illustrates the value of such head-to-head comparison studies in translational nanomedicine research.

Original languageEnglish (US)
Pages (from-to)458-466
Number of pages9
JournalACS Nano
Volume8
Issue number1
DOIs
StatePublished - Jan 28 2014

Fingerprint

glucocorticoids
Medical nanotechnology
arthritis
Liposomes
Micelles
releasing
Glucocorticoids
micelles
Polymers
drugs
formulations
Prodrugs
kinetics
polymers
rats
emerging
injection
dosage
optimization
Kinetics

Keywords

  • HPMA copolymer
  • dexamethasone
  • drug targeting
  • glucocorticoid
  • inflammation
  • liposome
  • micelle
  • nanomedicine
  • rheumatoid arthritis

ASJC Scopus subject areas

  • Materials Science(all)
  • Engineering(all)
  • Physics and Astronomy(all)

Cite this

Nanomedicines for inflammatory arthritis : Head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes. / Quan, Lingdong; Zhang, Yijia; Crielaard, Bart J.; Dusad, Anand; Lele, Subodh M; Rijcken, Cristianne J F; Metselaar, Josbert M.; Kostková, Hana; Etrych, Tomáš; Ulbrich, Karel; Kiessling, Fabian; Mikuls, Ted R; Hennink, Wim E.; Storm, Gert; Lammers, Twan; Wang, Dong.

In: ACS Nano, Vol. 8, No. 1, 28.01.2014, p. 458-466.

Research output: Contribution to journalArticle

Quan, L, Zhang, Y, Crielaard, BJ, Dusad, A, Lele, SM, Rijcken, CJF, Metselaar, JM, Kostková, H, Etrych, T, Ulbrich, K, Kiessling, F, Mikuls, TR, Hennink, WE, Storm, G, Lammers, T & Wang, D 2014, 'Nanomedicines for inflammatory arthritis: Head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes', ACS Nano, vol. 8, no. 1, pp. 458-466. https://doi.org/10.1021/nn4048205
Quan, Lingdong ; Zhang, Yijia ; Crielaard, Bart J. ; Dusad, Anand ; Lele, Subodh M ; Rijcken, Cristianne J F ; Metselaar, Josbert M. ; Kostková, Hana ; Etrych, Tomáš ; Ulbrich, Karel ; Kiessling, Fabian ; Mikuls, Ted R ; Hennink, Wim E. ; Storm, Gert ; Lammers, Twan ; Wang, Dong. / Nanomedicines for inflammatory arthritis : Head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes. In: ACS Nano. 2014 ; Vol. 8, No. 1. pp. 458-466.
@article{c727f74d6a114b4dae8a8bf8d5e4d53e,
title = "Nanomedicines for inflammatory arthritis: Head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes",
abstract = "As an emerging research direction, nanomedicine has been increasingly utilized to treat inflammatory diseases. In this head-to-head comparison study, four established nanomedicine formulations of dexamethasone, including liposomes (L-Dex), core-cross-linked micelles (M-Dex), slow releasing polymeric prodrugs (P-Dex-slow), and fast releasing polymeric prodrugs (P-Dex-fast), were evaluated in an adjuvant-induced arthritis rat model with an equivalent dose treatment design. It was found that after a single i.v. injection, the formulations with the slower drug release kinetics (i.e., M-Dex and P-Dex-slow) maintained longer duration of therapeutic activity than those with relatively faster drug release kinetics, resulting in better joint protection. This finding will be instructional in the future development and optimization of nanomedicines for the clinical management of rheumatoid arthritis. The outcome of this study also illustrates the value of such head-to-head comparison studies in translational nanomedicine research.",
keywords = "HPMA copolymer, dexamethasone, drug targeting, glucocorticoid, inflammation, liposome, micelle, nanomedicine, rheumatoid arthritis",
author = "Lingdong Quan and Yijia Zhang and Crielaard, {Bart J.} and Anand Dusad and Lele, {Subodh M} and Rijcken, {Cristianne J F} and Metselaar, {Josbert M.} and Hana Kostkov{\'a} and Tom{\'a}š Etrych and Karel Ulbrich and Fabian Kiessling and Mikuls, {Ted R} and Hennink, {Wim E.} and Gert Storm and Twan Lammers and Dong Wang",
year = "2014",
month = "1",
day = "28",
doi = "10.1021/nn4048205",
language = "English (US)",
volume = "8",
pages = "458--466",
journal = "ACS Nano",
issn = "1936-0851",
publisher = "American Chemical Society",
number = "1",

}

TY - JOUR

T1 - Nanomedicines for inflammatory arthritis

T2 - Head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes

AU - Quan, Lingdong

AU - Zhang, Yijia

AU - Crielaard, Bart J.

AU - Dusad, Anand

AU - Lele, Subodh M

AU - Rijcken, Cristianne J F

AU - Metselaar, Josbert M.

AU - Kostková, Hana

AU - Etrych, Tomáš

AU - Ulbrich, Karel

AU - Kiessling, Fabian

AU - Mikuls, Ted R

AU - Hennink, Wim E.

AU - Storm, Gert

AU - Lammers, Twan

AU - Wang, Dong

PY - 2014/1/28

Y1 - 2014/1/28

N2 - As an emerging research direction, nanomedicine has been increasingly utilized to treat inflammatory diseases. In this head-to-head comparison study, four established nanomedicine formulations of dexamethasone, including liposomes (L-Dex), core-cross-linked micelles (M-Dex), slow releasing polymeric prodrugs (P-Dex-slow), and fast releasing polymeric prodrugs (P-Dex-fast), were evaluated in an adjuvant-induced arthritis rat model with an equivalent dose treatment design. It was found that after a single i.v. injection, the formulations with the slower drug release kinetics (i.e., M-Dex and P-Dex-slow) maintained longer duration of therapeutic activity than those with relatively faster drug release kinetics, resulting in better joint protection. This finding will be instructional in the future development and optimization of nanomedicines for the clinical management of rheumatoid arthritis. The outcome of this study also illustrates the value of such head-to-head comparison studies in translational nanomedicine research.

AB - As an emerging research direction, nanomedicine has been increasingly utilized to treat inflammatory diseases. In this head-to-head comparison study, four established nanomedicine formulations of dexamethasone, including liposomes (L-Dex), core-cross-linked micelles (M-Dex), slow releasing polymeric prodrugs (P-Dex-slow), and fast releasing polymeric prodrugs (P-Dex-fast), were evaluated in an adjuvant-induced arthritis rat model with an equivalent dose treatment design. It was found that after a single i.v. injection, the formulations with the slower drug release kinetics (i.e., M-Dex and P-Dex-slow) maintained longer duration of therapeutic activity than those with relatively faster drug release kinetics, resulting in better joint protection. This finding will be instructional in the future development and optimization of nanomedicines for the clinical management of rheumatoid arthritis. The outcome of this study also illustrates the value of such head-to-head comparison studies in translational nanomedicine research.

KW - HPMA copolymer

KW - dexamethasone

KW - drug targeting

KW - glucocorticoid

KW - inflammation

KW - liposome

KW - micelle

KW - nanomedicine

KW - rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=84893472683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893472683&partnerID=8YFLogxK

U2 - 10.1021/nn4048205

DO - 10.1021/nn4048205

M3 - Article

VL - 8

SP - 458

EP - 466

JO - ACS Nano

JF - ACS Nano

SN - 1936-0851

IS - 1

ER -